Future opportunity

Provision of a Chemotherapy ePrescribing Solution

  • Imperial College Healthcare NHS Trust

F01: Prior information notice (prior information only)

Notice reference: 2021/S 000-012111

Published 29 May 2021, 11:38pm



Section one: Contracting authority

one.1) Name and addresses

Imperial College Healthcare NHS Trust

St Mary's Hospital, Praed Street

London

W21NY

Contact

Lee Matthews

Email

lee.matthews2@nhs.net

Country

United Kingdom

NUTS code

UKI32 - Westminster

Internet address(es)

Main address

https://www.imperial.nhs.uk

Buyer's address

https://www.imperial.nhs.uk

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

Additional information can be obtained from the above-mentioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

http://health.atamis.co.uk

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Provision of a Chemotherapy ePrescribing Solution

two.1.2) Main CPV code

  • 85149000 - Pharmacy services

two.1.3) Type of contract

Services

two.1.4) Short description

The provision of a Chemotherapy ePrescribing System including Maintenance and Support for a period of up to 10 years

two.1.5) Estimated total value

Value excluding VAT: £2,100,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 48000000 - Software package and information systems
  • 72000000 - IT services: consulting, software development, Internet and support

two.2.3) Place of performance

NUTS codes
  • UKI32 - Westminster

two.2.4) Description of the procurement

Imperial College Healthcare NHS Trust, acting as Lead Authority, intends to run a collaborative procurement project on behalf of 4 NHS Trusts in North West London (1. Chelsea and Westminster Hospital NHS Foundation Trust, 2. Imperial College Healthcare NHS Trust, 3. London North West University Healthcare NHS Trust & 4. The Hillingdon Hospital NHS Foundation Trust) for the provision of a Chemotherapy ePrescribing solution over a period of up to 10 years. Aside from utilising a PIN to notify the market of the collaborative Trust’s intentions, we also wish to conduct formal preliminary market consultation in accordance with Regulations 40 and 41 of the Public Contract Regulations (PCR) 2015. Potential bidders are invited to complete and return Appendix 1 – Soft Market Testing Questionnaire of ‘Preliminary Market Consultation (Pre-Procurement Engagement) Document’ which requests feedback on specific elements of the intended procurement process and draft specification. Completion of the questionnaire will in no way obligate your organisation to tender and confidentiality will be kept for the purpose of preparing the tender exercise. Conversely, failing to participate in this process will in no way preclude your organisation from participating in a future related tender.

two.2.14) Additional information

Participation in this Preliminary Market Consultation exercise is entirely voluntary. Participation or a lack of participation will have no bearing during any future tender exercise.

two.3) Estimated date of publication of contract notice

29 May 2021


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No